Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsDagsdóttir, Heiður Mist
Baldvinsdóttir, Guðrún Erna
MetadataShow full item record
CitationSpringerplus 2014, 3:524
AbstractHerpes simplex encephalitis (HSE) is a serious disease with 10-20% mortality and high rate of neuropsychiatric sequelae. This study is a long-term, nationwide study in a single country, Iceland. Clinical data were obtained from patient records and from DNA PCR and antibody assays of CSF. Diagnosis of HSE was classified as definite, possible or rejected based on symptoms, as well as virological, laboratory and brain imaging criteria. A total of 30 definite cases of HSE were identified during the 25 year period 1987-2011 corresponding to incidence of 4.3 cases/106 inhabitants/year. Males were 57% of all patients, median age 50 years (range, 0-85). Fever (97%), cognitive deficits (79%), impaired consciousness (79% with GCS < 13), headache (55%) and seizures (55%) were the most common symptoms. Brain lesions were found in 24 patients (80%) by MRI or CT. All patients received intravenous acyclovir for a mean duration of 20 days. Three patients (10%) died within one year and 21/28 pts (75%) had a Karnofsky performance score of <70% with memory loss (59%), dysphasia (44%), frontal symptoms (44%) and seizures (30%) as the most frequent sequelae. Mean delay from onset of symptoms to treatment was 6 days; this was associated with adverse outcome. In conclusion, the incidence of `HSE is higher than recently reported in a national registry study from Sweden. Despite advances in rapid diagnosis and availability of treatment of HSE, approximately three of every four patients die or are left with serious neurological impairment.
DescriptionTo access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked Files. This article is open access.
- Herpes simplex encephalitis in Sweden, 1990-2001: incidence, morbidity, and mortality.
- Authors: Hjalmarsson A, Blomqvist P, Sköldenberg B
- Issue date: 2007 Oct 1
- Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's.
- Authors: Tyler KL
- Issue date: 2004 Jun
- Incidence and mortality of herpes simplex encephalitis in Denmark: A nationwide registry-based cohort study.
- Authors: Jørgensen LK, Dalgaard LS, Østergaard LJ, Nørgaard M, Mogensen TH
- Issue date: 2017 Jan
- [Herpes simplex encephalitis in Cáceres. An analysis of the last five years].
- Authors: Sánchez Muñoz-Torrero JF, Luengo-Alvarez J, Casado-Naranjo I, Ramírez-Moreno JM, Ruiz-Llano F, Costo-Campoamor A
- Issue date: 2005 May 1-15
- Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome.
- Authors: McGrath N, Anderson NE, Croxson MC, Powell KF
- Issue date: 1997 Sep